{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-22-001896","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2022-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.386806+00:00","generated_at":"2026-06-23T21:21:20.154569+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Artelo Biosciences regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq letter confirming compliance with Listing Rule 5550(a)(2) on August 24, 2022.","Common stock bid price closed at or above $1.00 for required period, closing the matter.","Company avoids potential delisting risk from Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-22-001896","json":"https://secwatch.observer/filing/0001640334-22-001896.json","markdown":"https://secwatch.observer/filing/0001640334-22-001896.md","text":"https://secwatch.observer/filing/0001640334-22-001896.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033422001896/0001640334-22-001896-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033422001896/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T21:21:20.154569+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}